Neutropenia: what abnormal blood counts can mean for your health

Written by: Dr Jonathan Sive
Published:
Edited by: Bronwen Griffiths

Having a low blood count can put you at an increased risk to certain problems, and when your white blood cell count is low, you are more prone to contracting infections. In fact, sometimes it is repeated infections that send people to the doctor initially, before being diagnosed with an abnormal blood count. One such type of blood count is a neutrophil count, but what are neutrophils? Dr Jonathan Sive, a top haematologist, explains what they are and what a low neutrophil count can mean for your health.

What is neutropenia?

Neutrophils are one of the main types of white blood cells and they are important for protecting the body against bacterial infection. Neutrophil numbers are counted as a part of a standard full blood count (FBC), and should normally be in the range of 2.0-7.0 x 109/L, although specific normal ranges may vary slightly between hospital laboratories. Neutropenia is a neutrophil count which is reduced below this range.

Neutropenia can be divided into mild, moderate and severe, based on the count:

  • Mild = 1.0-1.5 x109/L
  • Moderate = 0.5-0.9 x109/L
  • Severe = <0.5 x109/L

Read more: Blood disorders

What are the symptoms of neutropenia?

Neutropenia is often an incidental finding which does not cause any symptoms. If neutropenia is moderate or severe it can put people at an increased risk of infection, which may well be the problem they initially go to the doctor with. This can vary from a mild infection that is managed by a GP, or a more serious infection that leads to hospital admission.

What are the possible causes of neutropenia?

Neutropenia can be a racial-variant: African and African-Caribbean people often have a low neutrophil count, which is normal. Some drugs can cause neutropenia, as can viral infections, some auto-immune conditions and occasionally vitamin deficiencies. In some cases, neutropenia may be due to a problem in the bone marrow, and if it is persistent without an obvious explanation, then review by a haematologist is recommended.

What investigations are required?

Standard investigations can usually be done with blood tests from the clinic. Occasionally, a bone marrow biopsy is required – this involves taking a small sample from inside the bone at the top of the hip. This is a day-case procedure that is done under local anaesthetic and it allows more detailed tests to be done on the maturing blood cells.

What treatment may be required?

In many cases, no specific treatment is required, apart from regular monitoring, and prompt antibiotics for any infections. If the neutrophil count is persistently very low, then sometimes preventative antibiotics and antiviral medications may be recommended to reduce the risk of infection. Growth factor injections are also occasionally used to increase the neutrophil count. Specific treatment for a bone marrow problem depends on the nature of the condition and should be managed by a haematologist.

 

Dr Jonathan Sive works at the renowned UCLH Macmillan Cancer Centre in London where he treats patients with blood disorders, blood cancer and abnormal blood counts.

By Dr Jonathan Sive
Haematology

Dr Jonathan Sive is an expert haematologist based in London. He specialises in the diagnosis and management of blood cancers, with particular expertise in the treatment of myeloma and other related disorders. He is the Clinical Service Lead for the UCLH myeloma service - the largest in the UK, and has a specialist interest in POEMS Syndrome.He is also highly experienced in the investigation of abnormal blood counts and paraproteins.

After qualifying, he completed specialist training in haematology at University College London Hospital and carried out a PhD at Cambridge University, where he investigated the use of genomic technologies to study the mechanisms of leukaemia development. He currently practises as a consultant haematologist at University College London Hospital, where he also has a private practice

Dr Sive is committed to research which improves treatment outcomes for all patients. In this respect, he is actively engaged in a variety of clinical research projects and takes a leading role in the development of national guidelines.

He is the lead author of the new UK national guidelines for the diagnosis and initial treatment of myeloma. These are published by the British Society for Haematology and the UK Myeloma Forum, and provide the standard for practice throughout the UK. https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.17410

His work has been widely published in numerous peer-reviewed journals and book chapters. He is also a member of the British Society for Haematology (BSH) and the UK Myeloma Research Alliance, and is member of the executive committee of the UK Myeloma Forum.

A skilled clinician, Dr Sive combines his academic expertise in blood disorders with dedication to delivering an excellent standard of care to every patient. He is known for his clear and empathetic communication style and will explore all treatment options relevant to the patient’s circumstances in an honest and sensitive manner.

To reduce infection risk during the Covid19 outbreak, he is able to offer consultations by telephone or videocall.

View Profile

Overall assessment of their patients


  • Related procedures
  • Thrombosis
    Growth factors
    Bone marrow cancers
    Pancreatic cancer
    Pulmonary embolism
    Immunotherapy
    Anaemia
    Alteration of red blood cells
    Multiple myeloma
    Myelodysplastic syndrome
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.